Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Ondivax Ondansteron Injection IP
Ondivax Ondansteron Injection IP is a highly effective medication designed to combat nausea and vomiting associated with cancer treatments and surgical procedures. Its active ingredient, Ondansteron, is a selective serotonin receptor antagonist that provides rapid relief from these distressing symptoms.
Uses of Ondivax Ondansteron Injection IP
Chemotherapy-Induced Nausea and Vomiting: Prevents and controls nausea and vomiting caused by cancer chemotherapy.
Radiation-Induced Nausea and Vomiting: Effective in preventing nausea and vomiting associated with radiation therapy.
Postoperative Nausea and Vomiting: Used to prevent and treat nausea and vomiting following surgery.
Benefits of Ondivax Ondansteron Injection IP
Rapid Relief: Provides quick onset of action to relieve nausea and vomiting.
Highly Effective: Proven efficacy in preventing and controlling nausea and vomiting from various causes.
Well-Tolerated: Generally well-tolerated with a favorable safety profile.
Convenient Administration: Injectable form allows for precise dosing and immediate action.
Mechanism of Action of Ondivax Ondansteron Injection IP
Serotonin Receptor Blockade: Blocks serotonin receptors in the brain and gastrointestinal tract, preventing the initiation of nausea and vomiting.
Central and Peripheral Action: Acts both centrally on the brain's vomiting center and peripherally in the gastrointestinal tract to provide comprehensive relief.
Selective Antagonism: Specifically targets 5-HT3 receptors, which are implicated in the emetic response, ensuring focused and effective action.